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Abstract 
 With a history that began in 800 A.D., coffee is the most popular drink known and as a 
result, the issues regarding its physiologic effects deserve attention. Maintaining alertness is a 
well-known benefit and in addition, the cardiovascular (CV) effects of the active compounds, 
which include polyphenols and caffeine, must be considered. Genetics are relevant and where 
slow caffeine metabolism is inherent, the risk of nonfatal myocardial (MI) has been shown to be 
increased. Overall risk for coronary heart disease (CHD) is not supported and unless there is 
excessive intake, congestive heart failure (CHF) is not adversely affected; in moderation, there 
may be some benefit for CHF. There is no apparent increased risk of sudden cardiac death 
(SCD). Overall, there also appears to be a beneficial inverse association with all-cause mortality, 
although this is not absolute for extra heavy intake. Benefit in reducing stroke also has 
supportive evidence. Hypertension is not increased by coffee. Boiled and unfiltered coffee 
appears to increase plasma cholesterol and triglycerides but for the overall metabolic syndrome, 
there appears to be benefit. There is also some evidence that paper-filtered coffee results in an 
increase in some markers of inflammation. Association of coffee with arrhythmias has been a 
major concern though in moderation it is not a significant overall problem. Therefore, only if a 
patient were to associate major arrhythmic symptoms with coffee would cessation have to be 
advised. Where coffee clearly shines from a CV standpoint is in the established decrease in onset 
of type 2 diabetes mellitus (DM). Any benefit or harm has always been attributed to caffeine as 
the apparent major component. However, coffee contains a myriad of compounds, including 
polyphenols. These other substances may be most relevant for potential benefit or harm and 
some of these may be partially removed or altered by coffee preparation methods such as paper 
filtration. Multiple studies support this by what appears to be no CV advantage or disadvantage 
for decaffeinated coffee. The bottom line on coffee, for those who enjoy the brew, is that it is a 
wonderful beverage with rare associated CV disadvantage and with much to recommend it from 
an overall CV standpoint. 
 
 
 
Key words: Cardiovascular, coffee, coronary heart disease, congestive heart failure, diabetes 
mellitus, myocardial infarction, sudden cardiac death.  
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Abbreviations: 
 ABI:  Ankle-brachial index 
AF:  Atrial fibrillation 
 ApoA-1: Apolipoprotein A-1 
 ApoB:  Apolipoprotein B 
 BP:  Blood pressure 
CGAs:  Chlorogenic acids 
CHD:  Coronary heart disease 
 CHF:  Congestive heart failure 
 CI:  Confidence interval 
 CQAs:  Caffeoylquinic acids 
CV:  Cardiovascular 
CYP1A2: Cytochrome P450 1A2  
 DM:  Diabetes mellitus 
 FMD:  Flow-mediated dilatation 
 HDL-C: High-density lipoprotein cholesterol 
 LDL:  Low-density lipoprotein 
 LDL-C: Low-density lipoprotein cholesterol 
 MetS:  Metabolic syndrome 
 MI:  Myocardial infarction 
 NAFLD: Non-alcoholic fatty liver disease  
 OR:  Odds ratio 
 PAD:  Peripheral arterial disease 
 RR:  Relative risk 
 SCD:  Sudden cardiac death 
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 Introduction 
 The history of coffee begins in 800 years A.D. in the Ethiopian highlands with the legend 
of Kaldi the goat herder.[1] While caring for his herd, Kaldi noted that after some of the goats 
ingested grains of a specific plant (that turned out to be coffee), they became more restless and 
playful. After sharing his observations with the abbot of a local monastery, Kaldi was requested 
to prepare a drink from the grains, and he subsequently shared it with the monks in the 
monastery. Thus, coffee was established as a desirable beverage and its use spread rapidly in the 
African locale, to the Arabian peninsula, and on to Europe.[2] The purpose of this article is to 
review the cardiovascular (CV) effects of the most popular drink in the world (Table 1).   
 
 
Brief summary of possible beneficial physiologic effects 
 Well accepted physiologic effects of coffee are its ability to help avoid somnolence and 
maintain alertness. The bioactive compounds in coffee appear to be chlorogenic acids (CGAs) 
which are polyphenols, caffeine, the pentacyclic diterpenes known as cafestol and kahweol, 
trigonelline, and melanoidins.[3] The CGAs consist of the caffeoylquinic acids (CQAs), 
especially 5-CQA, as well as lower amounts of feruloylquinic acids and dicaffeoylquinic acids. 
CQAs have an antioxidant effect but following ingestion of coffee, unmetabolized CQAs attain 
only a transient and low peak plasma concentration and cannot compete with more potent 
antioxidants in the body. It appears that a direct antioxidant effect for CGAs from coffee has 
been discarded. However, CGAs may have an antithrombotic effect by inhibiting platelet 
activity.[4] Both caffeic acid and 5-CQA from coffee have been shown to have antiplatelet 
activity with mice platelets in vitro and in vivo.[5] This appears to occur in association with 
suppressed expression of P-selectin, a biomarker for platelet activation. An anti-inflammatory 
effect of coffee may also be a beneficial effect. Dihydrocaffeic acid has been shown in human 
keratinocyte cells to have a down regulation of ultraviolet light-induced production of the 
proinflammatory cytokine interleukin-8.[6] Suggesting two other potentially beneficial effects, it 
has been shown that green coffee extract and 5-CQA given orally to hypertensive rats produced 
potentially beneficial alterations in blood pressure (BP) and endothelial function.[7] An effect on 
the latter was suggested by attenuation of the depressor effect from concurrent injection of 
atropine sulfate, mediated by the muscarinic acetylcholine receptors.  
 Caffeine is a major component of coffee and a major reason for its ingestion but for it or 
any bioactive component to benefit CV disease, it would have to improve major CV risk factors 
such as lipids or BP, or else have an in vivo antioxidant effect at physiological levels.[4] There 
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appears to be no major suggestion of a beneficial lipid effect of caffeine unless, by contributing 
to weight loss, it could indirectly decrease plasma lipids. In addition, caffeine itself has no low-
density lipoprotein (LDL) antioxidant effect though some caffeine metabolites such as 1-
methylxanthine and 1-methyluric acid are effective in preventing LDL oxidation.[8] The major 
polyphenol in coffee is CGA, which is an ester of caffeic acid and quinic acid. CGA is an in vitro 
antioxidant with 2 phenolic groups for radical scavenging by proton transfer. The apparent 
antioxidant content of coffee is 1.249 mmol/100 g.[9] It has been calculated that a 180 ml cup of 
brewed coffee provides 396 mg of polyphenols.[4] When this data is combined with per capita 
consumption of coffee, it appears that coffee is the largest source of antioxidants in the United 
States diet, potentially of significance for possible CV benefit.  
 
 
Genetics 
 The metabolism of caffeine contained in coffee occurs via the polymorphic cytochrome 
P450, 1A2 (CYP1A2) enzyme as the principal coffee metabolizing enzyme;[10-12] individuals 
homozygous for the CYP1A2*1A allele metabolize caffeine rapidly.[10] On the other hand, 
carriers of the variant CYP1A2*1F allele show a much slower caffeine metabolism. Cornelis et 
al. studied whether a specific CYP1A2 genotype changes the risk for acute myocardial infarction 
(MI).[10] These authors studied 2,014 cases of first acute nonfatal MI versus 2,014 controls, with 
both groups living in Costa Rica between 1994 and 2004, that were matched for age (median age 
59), sex, and area of residence. A total of 55% of cases (n=1,114) and 54% of controls (n=1,082) 
were carriers of the slow caffeine metabolism *1F allele. With the slow *1F allele carriers, the 
multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of nonfatal MI 
associated with the consumption of less than 1, 1, 2-3, and 4 or more cups of coffee per day were 
1.00, 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34), respectively.[10]  On the other 
hand, the ORs (95% CIs) for the rapid metabolizing *1A/*1A genotype were 1.00, 0.75 (0.51-
1.12), 0.78 (0.56-1.09, and 0.99 (0.66-1.48). For the gene-coffee interaction, P=0.04. Therefore, 
coffee consumption was associated with increased nonfatal MI risk only among individuals with 
slow caffeine metabolism in their study.[10]       
 
 
Sudden death 
 Bertoia et al. studied the possible role of alcohol and caffeine intakes in the development 
of sudden cardiac death (SCD) as studied in 93,676 postmenopausal women participating in the 
Women’s Health Initiative Observational Study, enrolled between 1993 and 1998, and followed 
until August 2009.[13] They found that one drink of alcohol per day (5.1-15 g/d) may have an 
association with a decreased SCD risk in this population of women but that the association had 
statistical significance for a model using the most recent alcohol intake. For coffee, the authors 
found no association between SCD and total caffeine intake in mg/d or total cups of caffeinated 
coffee, decaffeinated coffee. Also, no SCD association for caffeinated tea was found. 
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Arrhythmias 
 A major consideration for recommending a decrease in coffee and caffeine consumption 
is whenever there is a significant association with symptomatic arrhythmias, despite the absence 
of any association with increased SCD. Park and Grubb reported on a 38 year-old male patient 
with nausea, rapid palpitations, and presyncope, which occurred in association with the 
consumption of a large amount of strong French coffee.[14] His electrocardiogram showed a 
tachycardia with a slightly increased QRS duration of right bundle branch block pattern with left 
axis deviation and supraventricular tachycardia was initially diagnosed. With a subsequent 
electrophysiologic study, he was found to have a fascicular tachycardia as a rare presentation of 
ventricular tachycardia.  This was successfully treated with radiofrequency catheter ablation.  
 Any relationship of the most prevalent sustained arrhythmia, atrial fibrillation (AF), to 
coffee and caffeine appears to be supported only by heterogeneous data in the available literature 
as evaluated by Caldeira et al.[15] These authors assessed the association between chronic 
exposure to caffeine and AF. The following were used as data sources up to and including 
December 2012: PubMed, CENTRAL, ISI Web of Knowledge and LILACS. They used 7 
observational studies including 115,993 individuals with 6 cohorts and one case-control study. 
Caffeine was not related to increased AF risk (OR 0.92, 95% CI 0.82 to 1.04). For low-dose 
caffeine, it even appeared that there might be a protective effect to decrease AF risk (OR 0.85, 
95% CI 0.78 to 0.92). In addition, exposure to caffeine that was related exclusively to drinking 
coffee had no influence on AF. In an editorial analysis of the publication of Caldeira et al.,[15] 
Bhave and Hoffmayer[16] concluded that the available data supported that low to moderate 
consumption of caffeine is safe in regard to not causing AF, that caffeine in moderation does not 
appear to promote cardiac dysrhythmias; nevertheless, there did not appear to be sufficient data 
to establish coffee as protective.[16]    
 
 
Diabetes mellitus (DM) 
 Publications on possible health effects of coffee have undergone extensive study. 
Multiple population studies have assessed the relationship of coffee drinking and type 2 DM and 
have concluded that frequent coffee drinking appears to decrease the risk of type 2 DM.[17] 
However, data regarding habitual coffee consumption and type 2 DM risk are very recent as 
reviewed by Muley et al.[18] These authors studied 13 cohort studies that included 47,387 
participants, and 9,473 incident cases of type 2 DM. The risk of DM was assessed with different 
degrees of coffee consumption. It was concluded that regular consumption of coffee is associated 
with a decreased risk of type 2 DM. The participants that drank 4 to 6 cups and those that drank 
over 6 to 7 cups of coffee each day had a lesser type 2 DM risk than those participants who drank 
less than 2 cups per day. There appeared to be an advantage of filtered coffee over pot-boiled 
coffee. Muley et al. actually reported an advantage of decaffeinated coffee over caffeinated 
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coffee.[18] Also, there was a stronger inverse correlation for type 2 DM in the age group under 
60 years. Nevertheless, these authors did not advocate the recommendation to increase the 
consumption of coffee as a public health policy, especially without widespread assessment of 
postprandial hyperglycemia and insulin sensitivity.[18] Jiang et al. studied the relationship of 
coffee and caffeine to type 2 DM patients by identification of studies they considered pertinent 
from a search of PubMed and EMBASE.[19] These authors performed a dose-response 
assessment showing that the occurrence of type 2 DM decreased by 12% (Relative Risk [RR] 
0.89, CI 0.82) when coffee intake was increased by 2 cups/day.[19] The decrease with 
decaffeinated coffee was almost as great and was found to be 11% (RR 0.86, CI 0.82-0.91) per 
every 2 cup/day increase. With caffeine intake, there was a 14% decrease in type 2 DM per every 
increase in caffeine of 200 mg/day (RR 0.86, CI 0.82-0.91).[19] Other analyses also support the 
benefit of coffee to decrease type 2 DM risk in response to dose.[20] Data from the Nurses’ 
Health Study (NHS) also support the benefit of decreased occurrence of type 2 DM with a 
combined assessment of caffeinated/decaffeinated coffee (RR 8%); the Health Professionals 
Follow-Up Study (HPFS) showed separate benefit with both caffeinated and decaffeinated coffee 
(RR 4% and 7%, respectively).[21] The decrease in type 1 DM was significant in the case of 
both the NHS and HPFS studies.   
Natella and Scaccini extensively reviewed the part played by coffee regarding the risk of 
DM.[22] Regarding a mechanism for the effect of coffee, they commented on the status of coffee 
as a complicated mixture of multiple substances that include, of course, caffeine, as well as 
phenols, niacin, fiber and minerals. These authors discussed that despite the good evidence for 
coffee in protecting against type 2 DM, there must be awareness of opposing reported results that 
describe an adverse effect of caffeine on glucose metabolism even with reports of associated 
hyperglycemia and decreased insulin sensitivity associated with caffeine.[22] They interpret their 
analysis as showing that these negative effects of caffeine are favorably altered when caffeine is 
present within coffee as a complex conglomeration of various substances and that regular coffee 
consumption has a protective benefit in decreasing the onset of type 2 DM. The authors 
considered that potential mechanisms to decrease type 2 DM associated with coffee, such as the 
presence of antioxidant effects (e.g. phenols) and anti-inflammatory effects (e.g. phenols) are 
considerations but these are without definitive proof. Therefore, there is still insufficient 
evidence to specifically recommend increased coffee consumption to prevent type 2 DM, despite 
the reported decrease in incidence. The situation regarding any benefit of coffee consumption for 
type 1 DM and gestational DM has definitely not been clarified.[22]     
 
 
Dietary considerations 
 Coffee is, or course, a major source of caffeine and caffeine can be considered a major 
dietary component due to its widespread use. Wierzejska, in an article in Polish, commented that 
women around Warsaw had an average daily caffeine consumption of 251 mg with 15% 
consuming in excess.[23] It currently appears that a dose of 400 mg of caffeine per day is not 
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associated with negative effects. The author states that there is an average daily consumption of 
caffeine in Europe that ranges from 280 to 490 mg with the highest consumption in Scandinavia 
due to a very high level of ingestion of coffee. There is a general recommendation that pregnant 
women eliminate coffee and caffeine from their diet and Wierzejska described caffeine 
metabolism in pregnancy as decreased also with free passage of caffeine and its metabolites 
across the placenta.[23] The average mean daily intake of caffeine in the United States has been 
reported by Barone and Roberts as 4 mg/kg with youth under age 18 consuming a mean daily 
amount of 1 mg/kg. Ground roasted coffee in an amount of 5 oz has 85 mg caffeine with 18 mg 
caffeine in a 6 oz cola.[24] For the supposedly average 80 kg man, this calculates out at 320 mg 
and it would appear that coffee is the major source although many groups concentrate on colas 
and “energy” drinks. To assess the above caffeine statistics, available statistics from 1999 
showed that the average daily consumption of coffee in the United States was 3.1 cups per day 
among coffee drinkers.[25] On a per capita basis in the United States, the approximate intake for 
men is 1.9 cups of coffee per day; for women, it is 1.4 cups of coffee per day. 
 
 
Cardiovascular (CV) risk  
General considerations 
 A major purpose of this article is to assess available data on coffee and CV risk. Ding et 
al. performed an extensive and recent meta-analysis of coffee consumption over a long term.[26] 
They interpreted their meta-analysis as suggesting a nonlinear relationship between CV risk and 
the consumption of coffee. Their data analysis supported that moderate consumption of coffee 
had an association with decreased CV risk. They found that the lowest CV risk occurred with 3-5 
cups of coffee per day, but exceeding that with what could be considered heavy coffee 
consumption, there was no associated increase in CV risk.[26] Multiple other extensive analyses 
have assessed CV risk. However, as discussed by O’Keefe et al., most information on the 
medical ramifications of coffee have utilized observational information and unfortunately, there 
is only a minimal number of randomized controlled trials. Therefore, the presence of only an 
association fails to prove causation.[27] Nevertheless, coffee is the major source of caffeine in 
the United States and there is a daily consumption of coffee by in excess of 150 million people 
there.[28] There is increasing information that individuals who drink coffee as compared to those 
who do not, may be less likely to go on in the future to have type 2 DM, stroke, depression, death 
from any cause, as well being less likely to develop neurodegenerative diseases, which include 
Parkinson’s disease and Alzheimer’s disease. Especially when coffee is taken without added 
cream, various syrups, or sugar, as a calorie-free drink, it offers a greater probability of health 
benefit, especially if there are no perceived adverse subjective effects.[28] Floegel et al. assessed 
data from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany 
study involving 42,659 participants.[29] Their analysis found that consumption of coffee of 4 or 
more cups of coffee per day, caffeinated or decaffeinated, compared to less than one cup per day, 
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was not associated with any significant change in risk for MI, stroke, or cancer, but the increased 
coffee consumption was linked to a decreased type 2 DM risk.  
Montagnana et al. looked at the results of multiple epidemiological studies that suggested 
a U-shaped relationship associated with the consumption of coffee and the occurrence of CV 
events, including mortality.[30] These authors concluded that lower CV risk was associated with 
low coffee consumption of less than one cup per day or associated with high consumption of 
coffee of 4 or more cups of coffee per day.  Surprisingly, an intermediate consumption of  2-4 
cups of coffee per day demonstrated higher CV risk. They suggested an explanation attributable 
to the different substances in coffee such as CGAs (which are polyphenols), possibly effective in 
decreasing CV risk by decreasing the aggregation of platelets, the incidence of type 2 DM, the 
occurrence of inflammation, and the incidence of hypertension. They associated a possible 
relationship of caffeine to decreased CV risk due to weight reduction, increased fibrinolysis, and 
increased arterial flow-mediated dilatation (FMD).[30]   
 
Method of preparation of coffee 
 How coffee is prepared may also be an issue as pointed out by Lopez-Garcia. Coffee 
prepared by a nonfiltered method such as boiled, French press, and espresso, does not remove 
diterpenes and has been shown to increase plasma total cholesterol and low-density lipoprotein 
cholesterol (LDL-C).[31] This adds some confusion in that nonfiltered coffee could contribute to 
increased CV risk, so it is important to review this issue. Ahola et al. studied 20 healthy 
volunteers and their consumption of strong boiled coffee and the same boiled coffee but passed 
through filter paper over 4 week periods, and crossed over for the volunteers.[32] These authors 
found that when consuming boiled unfiltered coffee, serum total cholesterol, LDL-C, 
triglycerides, and apolipoprotein B (apoB) levels were significantly higher than during the period 
of ingestion of the same, but filtered, coffee. High-density lipoprotein cholesterol (HDL-C) and 
apolipoprotein A-1 (apoA-1) levels were not altered by the preparation method in this study. 
They considered that whatever hypercholesterolemic factor is present in boiled coffee is, most 
likely, lipid soluble and absorbed by the paper filters. Van Dusseldorp et al. studied 64 healthy 
volunteers and found that total cholesterol, LDL-C, and apoB levels were higher in their group 
ingesting boiled but unfiltered coffee. HDL-C and apoA-1 as well as triglyceride levels did not 
differ significantly.[33] They found that serum campesterol level, which reflects cholesterol 
absorption, stayed constant whereas serum lathosterol, as a measure of cholesterol synthesis, 
increased 11% (p<0.05). The lathosterol/cholesterol ratio, however, remained the same. It 
appeared to van Dusseldorp et al. that removal of whatever hypercholesterolemic factor is 
present in boiled nonfiltered coffee, occurs by the retention of lipids during filtration.[33] 
Increased cholesterol biosynthesis or absorption when consuming boiled nonfiltered coffee did 
not appear to them to be a mechanism. Multiple other studies support an increase in total 
cholesterol, LDL-C, and apoB from the ingestion of boiled coffee.[34-37] Aro et al. also found a 
direct increase in total cholesterol, LDL-C, and apoB, as related to the amount of boiled coffee 
consumed.[36] On the other hand, boiled coffee does not appear to affect the actual protein and 
 10 
 
lipid composition of the LDL-C.[37] Rosmarin et al. studied filtered coffee alone in a moderate 
dose of 3.6 cups/d and their results supported the lack of any effect of filtered coffee on total 
cholesterol, LDL-C, apoB, and HDL-C after controlling for diet, use of coffee creamer, and 
cigarette smoking.[38] In a study of Israeli factory workers, Green and Harari obtained detailed 
information on the ingestion of coffee and tea and lipids in 3,838 Israeli men and 1,511 Israeli 
women.[39] They found an especially significant and positive association of increased total 
cholesterol and LDL-C with boiled coffee.  However, other results are not consistent as in the 
case of the study of filtered coffee by Fried et al. which reported that ingestion of 720 mL/d of 
caffeinated filtered coffee resulted in a statistically significant increase in plasma total 
cholesterol, which appeared to result from LDL-C and HDL-C increases.[40] Their results are 
not consistent with the mainstream regarding no LDL-C increase associated with filtered coffee 
and further specific clarification is needed.  Results from an Italian study of 8,983 subjects 
reported that 1-3 cups/d resulted in an adjusted increase in serum total cholesterol of 3.4 mg/dL 
(0.088 mmol/L) with an increase up to 9.6 mg/dL (0.248 mmol/L) in those drinking over 5 
cups/d.[41] In the Italian method, ground coffee is preheated with steam and water goes through 
the ground coffee at a higher temperature compared with other techniques of brewing.[41] These 
results appear consistent with the higher lipid levels reported with boiled nonfiltered coffee. 
However, inconsistent observations have been noted, as happened with the small study of 
D’Amicis et al. of 84 men in which the Italian method of brewing coffee showed no significant 
differences in total cholesterol, LDL-C, and HDL-C.[42] 
 Two coffee diterpines, cafestol and kahweol, present in unfiltered coffee, appear to be 
significant factors accounting for increased LDL-C [43, 44] as well as increased very low-
density lipoprotein cholesterol with also a slight reduction in HDL-C, according to van Tol et 
al.[43] They observed some increased activity of proteins in serum involved in transfer of lipids 
and suggested such an increase as a possible mechanism associated with the increased lipid 
levels with boiled coffee. De Roos specifically studied the effect of French-press coffee (a 
nonfiltered method with only a strainer to catch coffee grounds) in 46 subjects and found an 
associated persistent increase in cholesteryl ester transfer protein (CETP).[45] They suggested 
this as a potential contributing mechanism for the LDL-C increase in boiled, unfiltered coffee 
resulting from cafestol and kahweol. Another potential mechanism was studied by Rustan et al in 
HepG2 cells.[46] These authors found that cafestol and kahweol decreased the hepatic LDL-C 
receptors, which could be an explanation of increased LDL-C associated with these coffee-
related diterpines in boiled, nonfiltered coffee. 
 Phenolic acids with antioxidant activity may be a significant beneficial factor in coffee. 
In a study of 10 healthy volunteers who drank 200 mL of filtered coffee after an overnight fast, 
Natella et al. found increased resistance of LDL-C to oxidative modification.[47] They attributed 
this to the new presence of phenolic acids from coffee in LDL-C. Coffee is also a source of 
polyphenols which have also been shown to have antioxidant activity as well as decreasing 
vascular inflammation.[48] Both of these effects could offer significant benefit in reducing CV 
risk.  
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Coffee epidemiology and plasma lipids 
 Although much of the effect of coffee on plasma lipids can be explained by the method of 
preparation, overall epidemiology has to be considered and multiple studies show an increase in 
especially LDL-C and then associate this with increased CV risk. However, much confusion 
occurs in that there are also studies that show no increase in plasma lipids with caffeinated 
coffee. Williams et al. studied a small group of 77 men and found total cholesterol and LDL-C 
were ultimately related to the amount of coffee consumed.[49] These authors found that LDL-C 
and apoB were not related to a coffee intake of up to 2 cups/d but rather, were associated with a 
coffee ingestion of greater than 2-3 cups/d. On the other hand, Aro et al., in a brief study, 
assessed 12 healthy volunteers aged 33-45 and had the subjects consume, successively, for 3-
week intervals, 8 cups/d of instant caffeinated coffee (total caffeine 520 mg), instant tea (total 
caffeine 200 mg), or rose hip tea (no caffeine).[50] There were no resultant differences in total 
cholesterol, LDL-C, HDL-C, triglycerides and the authors concluded that caffeinated coffee has 
no detectable effect on these lipids in healthy individuals with normal lipids. The Beaver County 
study of 472 white men and women in Beaver County, Pennsylvania in 1981-1982 was reported 
by Donahue et al., and it was found that no coffee, coffee intake of 1-2 cups/d, and coffee intake 
of 3 or more cups/d, resulted in no effect on total cholesterol, LDL-C, HDL-C, apoB, or apoA-1 
in men or women.[51] The only significant lipid effect found was that women drinking 3 or more 
cups/d had significantly lower triglyceride concentrations (P<0.05), a finding of indeterminate 
CV significance. Paoletti et al. also reported that chronic coffee drinking did not affect total 
cholesterol, HDL-C, apoB, or apoA-1 in a group of healthy subjects.[52] This observation also 
appeared to hold for individuals with a high consumption of coffee. The extensive and famous 
Framingham Study also failed to resolve any relationship of coffee to CV disease. As reported by 
Wilson et al. in a combined analyses of 2,648 men with 549 cases of CV disease and 3,566 
women with 462 cases of CV disease, no association of CV disease and ingestion of coffee was 
found in smokers, nonsmokers, men, or women.[53] In this Framingham substudy, men had a 
significant negative association of coffee and total cholesterol whereas women had a positive 
association of coffee and LDL-C. Framingham appears to offer no clarification to the lipid issue 
but supports the absence of an increase in CV disease associated with caffeinated coffee.[53] To 
add further confusion to differences in various groups, Kohlmeier et al. studied the association of 
coffee consumption and lipids in 395 young adults randomly selected, and in 385 elderly adults, 
in Germany.[54] After adjusting for various confounding factors, they found statistically 
significant total cholesterol and LDL-C increases only in the group of younger men, which was 
not noted in their elderly subjects. Carson et al. also studied such an age relationship in a group 
of 1,035 elderly white women ranging in age from 65 to 90 and, after adjustments for interfering 
factors, found no significant association of total cholesterol, LDL-C, and HDL-C with 
caffeinated coffee.[55] 
Jee et al. performed a meta-analysis using a Medline search of English-language 
literature before December 1998, discussions with experts, and a bibliographic review that 
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resulted in the identification of 14 coffee-intake trials.[56] The result of their meta-analysis was 
an observation of a direct response relationship between coffee intake and total cholesterol as 
well as LDL-C (P<0.01). They found increases in the lipids studied in subjects with 
hyperlipidemia already present and in the trials involving boiled coffee.[56] In the trials with 
filtered coffee, there was only a small increase in total cholesterol, offering further support of 
filtration removal of lipid-augmenting substances. In another meta-analysis in 1993, Kokjohn et 
al. searched Medline back to 1965 with the requirement that articles utilized had to have 
involved original results, have reported serum total cholesterol, and have been peer-reviewed for 
publication.[57] They found that there was a positive association of increased total cholesterol 
with increased coffee drinking with the differences assessed for drinking 4 or more cups of 
coffee/d, less than 1 cup of coffee/d, or no coffee. Again, there was an increased relationship of 
boiled coffee to total cholesterol as compared to filtered, decaffeinated, or instant coffee. 
Consistent with this, Cai et al. searched several English and Chinese electronic databases, 
including 1,017 subjects, and found that coffee consumption and especially unfiltered coffee 
consumption resulted in increases in total cholesterol, LDL-C, and triglycerides, with the 
increases related to the level of coffee consumption.[58]   
 Diet has been considered to be a possible confounding effect to explain any association of 
increased coffee consumption with increased lipids. In assessing this possibility, Haffner et al. 
looked at any relationship between serum lipid levels and the drinking of caffeinated coffee and 
any other caffeinated drinks.[59] Their study was population-based and involved 1,228 women 
and 923 men. They found a positive association between the consumption of coffee versus total 
cholesterol and LDL-C, after taking into account age, alcohol, race, obesity, and tobacco use. 
Since Haffner et al. found no association of lipids with tea or colas, it suggested to them that 
their observation was not just due to caffeine.[59] As a result, they evaluated the possibility of a 
more atherogenic diet in association with increased use of coffee. In men, there was increased 
caloric intake from total fat, saturated fat, and cholesterol associated with increased use of 
coffee. However, this association did not hold in women in the study but nevertheless, 
consideration of the effect of diet appears valid but unresolved. Another dietary observation and 
caveat with coffee were pointed out by Cheung et al., who studied the effect of a single cup of 
coffee in 40 individuals, 60 min before drawing blood for analysis.[60] Their results showed that 
this one cup of coffee ingested an hour before phlebotomy caused a statistically significant, 
although minimal, increase in total cholesterol and HDL-C with black coffee, and in triglycerides 
when cream and sugar were added. 
 The relationship of coffee drinking and lipids as affected by smoking has also been 
assessed.  Jossa et al. reported on the Olivetti Heart Study of 856 coffee drinkers.[61] They 
performed adjustments for possible confounding factors. They found a statistically significant 
positive trend between coffee drinking and total cholesterol only in smokers, which suggested to 
the investigators that smoking status is key for any total cholesterol increase by coffee drinking. 
Such effects and differences show how difficult it is to clarify the association of coffee and 
lipids. 
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 The relationship of caffeine or other components of coffee also have to be considered 
regarding plasma lipids. Superko et al. studied 181 men who consumed caffeinated coffee for 2 
months as the control and then were randomized to decaffeinated coffee, or no coffee, for 2 
months.[62] They found that the switch from caffeinated to decaffeinated coffee actually resulted 
in increased LDL-C and apoB, whereas there was no increase in these lipid components in the 
no-coffee group. This, of course, suggested that instead of caffeine, another substance (or 
substances) in coffee might be the causative factor for increased LDL-C and apoB. A similar 
result regarding decaffeinated coffee was reported by van Dusseldorp et al., who studied 23 
women and 22 men aged 25-45 years who were drinking 4-6 cups of caffeinated coffee per 
day.[63] A randomized trial was set up for the participants to drink 5 cups of caffeinated coffee/d 
for a total of 6 weeks, then decaffeinated coffee for 6 weeks, or participate in reverse. It was 
found that the effect on total cholesterol, HDL-C, and triglycerides was essentially null and the 
authors concluded that going to decaffeinated coffee had no effect on lipids. Thompson made a 
similar conclusion in a review of the literature that in terms of CV disease, stating that there is no 
good reason to recommend a switch to decaffeinated coffee.[64] 
 In a Japanese study of 4,587 self-defense officials with an age range of 48-56 years, 
Miyake et al studied the association of instant coffee and brewed coffee to serum lipids and 
lipoproteins.[65] After adjusting for various life-associated parameters, the authors found no 
relationship whatsoever of any serum lipid or lipoprotein to brewed coffee ingestion. On the 
other hand, the use of instant coffee had a very significant association with an increase in LDL-C 
whereas there was an associated decrease in triglycerides. They found that per cup of instant 
coffee each day, the LDL-C increased 0.82 mg/dL (95% CI 0.29-1.35).[65] A possible 
explanation is that instant coffee is not filtered. 
 
Coronary heart disease (CHD) 
 In a review of coffee consumption and CHD, Gensini and Conti concluded that large 
prospective studies fail to support that a moderate consumption of caffeine, which they classified 
as <5 cups of coffee per day, significantly increases CHD risk.[66] They also determined that 
higher coffee intake data was so scanty that no definitive conclusion could be made despite some 
suggestion of a statistically significant association of CHD risk with the higher coffee intake.[66] 
Nawrot et al. investigated PubMed and Web of Science databases in a search for various triggers 
of nonfatal MI, resulting in 36 epidemiologic studies they considered of relevance to calculating 
a population-attributable fraction (PAF).[67] They found that the highest PAF trigger of a 
nonfatal MI was traffic exposure (7.4%).  Other assessed triggers included physical exertion 
(6.2%), anger (3.1%), heavy food ingestion (2.7%), favorable emotions (2.4%), and sexual 
activity (2.2%). Coffee consumption as a trigger in their analysis was noted to be at an upper 
mid-level (5.0%). Their interpretation was that prevalent small risks could possibly have 
important public health significance.[67] However “coffee consumption” was simply analyzed as 
“drinking coffee” and the relevance appears questionable but is mentioned in this article in an 
attempt to fairly consider all issues related to coffee intake. In an analysis of 11 prospective 
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studies published between 1966 and 1991, Myers and Basinski found no relationship of coffee 
consumption to the development of CHD and the conclusion they made appears to remain valid 
in the absence of any adjustment for other CV risk factors.[68] In a meta-analysis performed by 
Greenland on 22 studies of CHD death, MI, and coffee consumption, it was found that coffee 
drinkers of 5 or more cups per day had geometric mean rate ratios of association ranging from 
0.92 to 1.42 with it unlikely for there to be a ratio over 1.5 for 5 daily cups of coffee although a 
stronger relationship for consumption for 10 cups/day could not be excluded.[69] Greenland 
concluded that the evidence for an association of coffee with CHD events remained unclear.[69] 
Kawachi et al. analyzed 15 cohort studies and concluded that the available data indicated that 
any increase in CHD risk with regular coffee consumption was very minimal.[70] Sofi et al. also 
concluded from their study of 13 case-control studies and 10 cohort studies that prospective 
cohort studies with prolonged follow up, do not show a significant relationship between CHD 
and regular coffee drinking in spite of some reports of a significant relationship between high 
coffee intake and CHD from case-control studies.[71] In support, Wu et al. performed a meta-
analysis of 21 prospective cohort studies and reached the conclusion from their analysis that 
coffee does not increase CHD over a long period of time and they actually found that a moderate 
intake of coffee in women had an association with decreased CHD risk.[72] In conclusion, 
regarding coffee risk for CHD, at worst it appears very minimal (more likely neutral), and not a 
major risk factor. The assessment of Silletta and Marchioli supports this conclusion and points 
out the many analytical problems that include: insufficient adjustment for life-associated 
variables, the multiple active compounds in coffee with the potential for CV harm or benefit, the 
variable tolerance of the effects of caffeine with regular intake of coffee, cup size variability, 
methods of preparation, and the impracticality of randomized studies.[73] The appropriate 
clinical recommendation should be that regarding CHD, the patient should enjoy his or her 
coffee in moderation unless there is a direct association with bothersome symptoms. 
 
Peripheral arterial disease (PAD) 
 The association of PAD and CHD is high, especially when PAD is severe, so the 
presence of an effect of coffee on PAD has to be assessed also when evaluating any relationship 
to CV disease. Uemura et al, in a study of 540 Japanese men, assessed the effect of coffee on the 
ankle-brachial index (ABI).[74] After making adjustments for various interfering factors 
including LDL-C and HDL-C, it was found that increased coffee consumption has a minimal but 
significant (P=0.031) reverse association with ABI. This association of decreased ABI with 
coffee was not present with the ingestion of green tea. 
 
Congestive heart failure (CHF) 
 Mostofsky et al. performed a dose-response meta-analysis of a regular consumption of 
coffee and the risk of congestive heart failure (CHF).[75] Their meta-analysis included a total of 
5 prospective studies of coffee intake and the risk of CHF, which included 140,220 participants 
and a total of 6,522 episodes of CHF. The analysis of these authors resulted in a J-shaped 
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relationship in which 4 cups of coffee per day had a significant inverse association with CHF, as 
compared to no coffee intake.  On the other hand, there appeared to be an increased risk of CHF 
at a coffee intake > 4 cups per day.[75]  
 
Hypertension 
 As a major CV risk factor, hypertension must be looked at in terms of any relationship to 
the consumption of coffee. Sudano et al. commented that the seventh report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) 
did not consider limitation of coffee or other beverages containing caffeine, to have an indication 
and that this was unnecessary.[76] They commented on the more recent state of knowledge that 
regular, moderate coffee ingestion is not a health hazard and of the current possible association 
with CV risk benefit. However, Mesas et al. do note from a review of 5 clinical trials, that in 
already hypertensive patients, the consumption of caffeine in a dose of 200-300 mg can result in 
an increase in systolic BP of 8.1 mmHg and an increase in diastolic BP of 5.7 mmHg for ≥ 3 
h.[77] Nevertheless, these authors acknowledged that up-to-date evidence does not associate 
coffee intake over the long term with increased BP. Other studies on the consumption of coffee 
and its relationship to BP and hypertension confirm that there is no statistically significant effect 
of coffee drinking on an increase in BP or on the development of hypertension.[78, 79] 
Therefore, there appears to be no BP indication for recommending against moderate coffee 
consumption in such patients.  
 
Plasma lipids, metabolic syndrome (MetS) and inflammation 
 In a review of the effect of coffee on CV risk, Rebello and van Dam commented that the 
consumption of coffee is not associated with increased risk of CHD or fatal CV events and that 
there may be a weak association with decreased stroke and CHF risk.[80] Their review also 
found that unfiltered coffee result in an increase in LDL-cholesterol (LDL-C) and in 
triglycerides, whereas filtered coffee had no significant effect on plasma lipids. Bøhn et al. also 
commented that boiled coffee can contribute to an increased serum cholesterol. [81] In a rat 
model of human MetS, Panchal et al. found that a Colombian coffee extract given to rats fed a 
high-carbohydrate and high-fat diet to produce aspects of the MetS resulted in decreased glucose 
tolerance impairment, reduced hypertension, no change in abdominal obesity, and no change in 
any dyslipidemia.[82] Yesil and Yilmaz reviewed literature on the relation of consumption of 
coffee to metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) and found that in 4 
of 6 studies, there was an inverse association of coffee intake with risk for MetS, whereas the 
other 2 studies, without the protective effect, involved studies of young persons with low MetS 
prevalence.[83] In terms of NAFLD, all of the studies assessed by these authors showed a 
protective effect from consumption of coffee. In an assessment of endothelial function by FMD 
on the island of Ikaria, Greece, Siasos et al. reported a linear increase in FMD related to higher 
coffee consumption.[84]  Actually, a boiled Greek-style coffee showed a more significant 
increase in FMD when compared to other kinds of coffee drinks. Corrêa et al. studied results of 2 
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different types of coffee preparation on CV risk in 20 volunteers in good health, who consumed 
3-4 cups of coffee per day.[85] The 2 preparations were medium light roast and medium roast, 
both paper-filtered. Medium light roast increased total cholesterol by 10%, LDL-C by 12%, and 
soluble vascular cell adhesion molecule-1 (sVCAM-1) by 18%, whereas medium roast increased 
total cholesterol 12%, LDL-C 14%, and sVCAM-1 14%.[85] These authors interpreted their data 
as showing that the moderate intake of paper-filtered coffee may result in unfavorable effects on 
cholesterol and markers of inflammation. In a study of a total of 364 Japanese men, Mure et al. 
studied the effect of coffee drinking in relationship with the MetS risk score.[86] These authors 
observed a favorable tendency for coffee consumption to result in decreased biological markers 
of the MetS and to result in a favorable increase in adiponectin. On the other hand, increased 
visceral fat frequently associated with the MetS results in an unfavorable decrease in 
adiponectin. Related to these metabolic considerations is the antioxidant status of coffee. 
Richelle et al studied this and found  that coffee in soluble form has an antioxidant activity that is 
significant, is related to coffee intake, and that the antioxidant effect of the coffee has a long lag 
time of 292-948 min.[87] Interestingly, Richelle et al. found some differences in the type of 
coffee beans; green Robusta coffee beans had twice the antioxidant effect as did Arabica coffee 
beans, the difference of which was not significant after roasting.[87] In addition, it appears 
important that the antioxidant effect of coffee have a long lag time; Carru et al., in an in vitro 
copper sulphate-catalyzed study of LDL oxidation, found that the antioxidant effect of coffee 
ultimately switched to pro-oxidant when there was a significant prolonged lag time.[88]   
 
Stroke 
 Any association of coffee with the occurrence of stroke needs to be considered on its 
own. The best available information appears to have been found in observational meta-analyses 
and there has been an inconsistent association of coffee intake with stroke risk. However, in a 
meta-analysis of 11 prospective studies, including 10,003 stroke patients from 479,689 
individuals, Larsson and Orsini found some evidence of an association of coffee intake and 
stroke risk that was nonlinear.[89] They found RRs as follows: 2 cups per day: RR 00.86; 3-4 
cups per day: RR 0.83; 6 cups per day: RR 0.87; and for 8 cups per day, RR 0.93. These authors 
concluded that moderate coffee intake may have a weak inverse association with stroke risk. In 
another meta-analysis, Kim et al. looked at 9 studies regarding stroke risk and the use of coffee 
and found that increased coffee consumption had a preventive advantage by decreasing stroke 
incidence. Those drinking 4 or more cups of coffee per day had RR 0.83 (95% CI, 0.75-
0.91).[90] In contrast, a combined analysis of sugar-sweetened soda intake from the Nurses’ 
Health Study and the Health Professionals Follow-Up Study showed a pooled RR 1.16 (95% CI, 
1.00-1.34) for total stroke incidence compared to one cup caffeinated coffee per day, with a 9% 
decreased stroke risk (95% CI, 0-17%), and one cup decaffeinated coffee per day with 10% 
decreased stroke risk (95% CI, 1-19%).[91] In a recent article, Larsson assessed that available 
prospective studies have found in general a weak inverse association between moderate coffee 
intake and stroke risk.[92] On the other hand, Lee et al performed a case-control study of 940 
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patients with acute hemorrhagic stroke not involving head injury, and found that using 
medications containing caffeine was associated with increased risk of hemorrhagic stroke, 
including both subarachnoid and intracerebral hemorrhage.[93] Analysis of available data 
therefore supports coffee and its myriad other substances and not caffeine as offering some 
protection from stroke. 
 
Mortality 
 The relationship of coffee to mortality is another issue for consideration that was 
addressed by Freedman et al. in an extensive analysis of total cause-specific mortality involving 
229,119 men and 173,141 women, aged 50-71 years as a prospective study.[94] They found that 
the consumption of coffee was inversely associated with total and cause-specific mortality but 
considered that their data could not define whether coffee was just an association vs. having 
status as a causative factor. In another meta-analysis, Je and Giovannucci performed a meta-
analysis on 129,538 deaths involving 973,904 participants from 20 studies.[95] Their analysis 
showed an RR for total mortality for high vs. low coffee intake to be 0.86 (95% CI, 0.80-0.92), 
and for those studies defining heavy coffee use as ≥ 2-4 cups per day or heavy intake as ≥ 5-9 
cups per day, there was a significant difference and they were similar. This favorable inverse 
association had a stronger tendency in European and Japanese studies than for the United States 
where the risk favorable inverse association with coffee consumption was less. The favorable 
inverse association was present for both men and women and their ultimate interpretation was 
that the consumption of coffee is related to decreased mortality risk.[95] Malerba et al. also 
performed a review and meta-analysis on the association of coffee with all-cause mortality and 
CV mortality.[96] They reported that their quantitative evidence supported the fact that the 
consumption of coffee decreases all-cause mortality and probably CV disease mortality. On the 
other hand, Liu et al. analyzed data from the Aerobics Center Longitudinal Study with 43,727 
participants.[97] In this large group, these authors found that heavy coffee intake, defined as 
more than 28 cups per week, had a positive correlation with all-cause mortality in both men and 
women who were less than 55 years of age. Therefore, Liu et al. stated that it appeared indicated 
to suggest that individuals at a younger age should avoid such heavy coffee drinking.[97] 
However, in a subsequent follow up, Liu et al. noted that it may be premature to render advice on 
a limitation of coffee drinking.[98]   
 
Specific vascular effects of coffee 
 There are multiple possible vascular effects of coffee, a comprehensive discussion of 
which is beyond the scope of this selected overview. However, it appears appropriate to 
summarize some of the possible considerations. Schechter et al. looked at essentially the 
immediate effect of caffeine ingestion on endothelial function as assessed by brachial artery 
FMD.[99] There were 40 controls free of known CHD and 40 matched participants with known 
CHD. Participants from both groups were given either placebo or a 200 mg caffeine capsule 
while in a fasting state and with no caffeine in excess of 48 h. In participants, both with and 
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without CHD, it was observed that 1 h after caffeine consumption, there was a significant 
improvement in endothelial function as evaluated by brachial artery FMD and decreased high-
sensitivity C-reactive protein as a marker of reduced inflammation,[99] both representing 
potential benefit to the CV system. Reis et al, in the Coronary Artery Risk Development in 
Young Adults (CARDIA) Study, assessed the effect of coffee and caffeine on carotid artery 
intima-media thickness and on coronary artery calcium score out to 20 years of follow up.[100] 
These authors found no significant association between coffee or caffeine on either measure of 
vascular atherosclerosis,[100] consistent with at least no harmful effects. Catalano et al. studied 
the effect of coffee on 137 patients with non-alcoholic fatty liver disease (NAFLD) and 108 
controls.[101] They found that coffee consumption was associated with decreased NAFLD and 
decreased insulin resistance,[101] both of potential metabolic and vascular benefit. NAFLD is 
associated with metabolic syndrome and increased vascular risk.[102] In a study on the 
cremasteric arteries of mice, Toda et al. found that the administration of coffee appeared to have 
a beneficial effect in preventing thrombus development in arteries whose endothelial function 
had been unfavorably altered by the administration of ferric chloride.[103] These authors did not 
find this beneficial effect with caffeine administration alone and their study supports further 
interest in specific non-caffeine coffee effects on the vasculature.[103] The studies just discussed 
are a sample of the extensive reported information to be considered regarding the effects of 
coffee at the vascular level, a full consideration of which is not possible in this overview (or in 
any single overview).   
 
   
Conclusions 
 The status of coffee as offering benefit in decreasing CV risk remains unresolved from a 
hard, universally-accepted numbers standpoint. Nevertheless, there is favorable evidence that, 
unless there is a specific high-risk genetic abnormality, coffee consumption has supportive 
evidence for a reduction in all-cause mortality and a reduction in CV mortality. The data is much 
stronger in support of a decreased incidence of type 2 DM with an established and accepted 
benefit of coffee consumption in regard to this disease. The complex chemistry of coffee needs 
much study and understanding such as the apparent higher CV risk associated with unfiltered 
boiled coffee and the potentially harmful plasma lipid-elevating components that may be 
removed by filtration. In general, appropriate advice by the clinician to his or her patients is that 
coffee is to be enjoyed by them, even when they are in the highest category of CV risk, if they 
like the beverage. Only if coffee is associated with bothersome symptomatic CV manifestations 
such as arrhythmias, should limitation or cessation be suggested. 
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Table 1: Summary of the beneficial and harmful effects of coffee. 
Probable benefit Definite benefit Probable harm Definite harm 
Possible decreased cardio-
vascular (CV) risk due to 
weight reduction, increased 
fibrinolysis, and increased 
arterial flow-mediated dilata-
tion (FMD).[30] 
Decreased onset of type 2 
diabetes mellitus 
(DM).[18-20] This 
appears well established. 
Increased congestive heart 
failure (CHF) with coffee intake 
over 4 cups per day.[75] 
Increased nonfatal 
myocardial infarction 
(MI) in the presence of 
slow caffeine 
metabolism.[15] 
Some suggestion of 
decreased overall stroke 
risk.[89-91]  
 Variable association of coffee 
with mild increases in plasma 
cholesterol, low-density 
lipoprotein cholesterol (LDL-
C), and triglycerides.[58, 81, 
85] 
 
General decrease in all-cause 
mortality risk.[94-96] 
 Increased all-cause mortality 
under age 55 years with heavy 
coffee intake.[97] 
 
 
 
